Biologic therapies for asthma in underserved populations.
作者信息
Kelly Rachel S, Weiss Scott T
机构信息
Channing Division of Network Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston MA 02115, USA.
Channing Division of Network Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston MA 02115, USA.
出版信息
Lancet. 2022 Aug 13;400(10351):471-473. doi: 10.1016/S0140-6736(22)01383-6.
Abstract
摘要
相似文献
1
Biologic therapies for asthma in underserved populations.针对医疗服务不足人群的哮喘生物疗法。
Lancet. 2022 Aug 13;400(10351):471-473. doi: 10.1016/S0140-6736(22)01383-6.
2
Bringing Care to Underserved and Vulnerable Patient Populations: Meeting Patients Where They Are.
Med Care. 2022 Jan 1;60(1):1-2. doi: 10.1097/MLR.0000000000001671.
3
Involving underserved patient populations in research.
BMJ. 2018 Oct 24;363:k4385. doi: 10.1136/bmj.k4385.
4
Environmental Health in Underserved Populations.
J Transcult Nurs. 2023 Nov;34(6):401. doi: 10.1177/10436596231205663. Epub 2023 Oct 11.
5
Differences in Uptake of Risk Reduction Strategies Among Underserved Populations.服务不足人群在风险降低策略采用方面的差异。
EBioMedicine. 2015 Nov 3;2(11):1598-9. doi: 10.1016/j.ebiom.2015.11.001. eCollection 2015 Nov.
6
Reducing Health Disparities in Underserved Populations.减少服务不足人群的健康差距。
Popul Health Manag. 2021 Aug;24(4):417. doi: 10.1089/pop.2021.29005.cfp. Epub 2021 Aug 6.
7
Beyond the : "An Algorithmic Approach to Reducing Unexplained Pain Disparities in Underserved Populations".超越《：一种减少弱势群体中不明原因疼痛差异的算法方法》。 （原文中":"处内容缺失，翻译可能存在一定局限性）
AJR Am J Roentgenol. 2021 Dec;217(6):1480. doi: 10.2214/AJR.21.26020. Epub 2021 Apr 28.
8
Reducing Health Disparities in Underserved Populations.减少服务不足人群的健康差距。
Popul Health Manag. 2021 Oct;24(5):527. doi: 10.1089/pop.2021.29005.cfp2.
9
Reply to: "Accessibility of direct-to-consumer teledermatology to underserved populations".回复：“面向服务不足人群的直接面向消费者的远程皮肤病学服务的可及性”
J Am Acad Dermatol. 2022 Mar;86(3):e135. doi: 10.1016/j.jaad.2021.10.044. Epub 2021 Oct 30.
10
Accessibility of direct-to-consumer teledermatology to underserved populations.直接面向消费者的远程皮肤病学服务对服务不足人群的可及性。
J Am Acad Dermatol. 2022 Mar;86(3):e133-e134. doi: 10.1016/j.jaad.2021.10.043. Epub 2021 Oct 30.
引用本文的文献
1
Cockroach allergy: Understanding complex immune responses to develop novel therapies.蟑螂过敏：了解复杂的免疫反应以开发新的疗法。
Mol Immunol. 2023 Apr;156:157-169. doi: 10.1016/j.molimm.2023.03.001. Epub 2023 Mar 15.
本文引用的文献
1
Mepolizumab for urban children with exacerbation-prone eosinophilic asthma in the USA (MUPPITS-2): a randomised, double-blind, placebo-controlled, parallel-group trial.美泊利珠单抗治疗美国易恶化型嗜酸性粒细胞性哮喘城市儿童（MUPPITS-2）：一项随机、双盲、安慰剂对照、平行分组试验。
Lancet. 2022 Aug 13;400(10351):502-511. doi: 10.1016/S0140-6736(22)01198-9.
2
Biologic Therapies for Severe Asthma.重度哮喘的生物疗法
N Engl J Med. 2022 Jan 13;386(2):157-171. doi: 10.1056/NEJMra2032506.
3
Need for Racial and Ethnic Diversity in Asthma Precision Medicine.哮喘精准医学中种族和民族多样性的必要性。
N Engl J Med. 2021 Dec 9;385(24):2297-2298. doi: 10.1056/NEJMe2114944.
4
Gender bias in clinical trials of biological agents for severe asthma: A systematic review.生物制剂治疗严重哮喘临床试验中的性别偏见：系统评价。
PLoS One. 2021 Sep 23;16(9):e0257765. doi: 10.1371/journal.pone.0257765. eCollection 2021.
5
Endotype of allergic asthma with airway obstruction in urban children.城市儿童气道阻塞性变应性哮喘的表型。
J Allergy Clin Immunol. 2021 Nov;148(5):1198-1209. doi: 10.1016/j.jaci.2021.02.040. Epub 2021 Mar 10.
6
The use of biologic therapies for the management of pediatric asthma.生物疗法在小儿哮喘管理中的应用。
Pediatr Pulmonol. 2020 Mar;55(3):803-808. doi: 10.1002/ppul.24613. Epub 2019 Dec 27.
7
Transcriptome networks identify mechanisms of viral and nonviral asthma exacerbations in children.转录组网络鉴定儿童病毒和非病毒哮喘恶化的机制。
Nat Immunol. 2019 May;20(5):637-651. doi: 10.1038/s41590-019-0347-8. Epub 2019 Apr 8.
8
Cost-effectiveness and comparative effectiveness of biologic therapy for asthma: To biologic or not to biologic?哮喘生物治疗的成本效益和比较效果：用生物制剂还是不用生物制剂？
Ann Allergy Asthma Immunol. 2019 Apr;122(4):367-372. doi: 10.1016/j.anai.2019.01.018. Epub 2019 Jan 28.
9
Assessing the value of mepolizumab for severe eosinophilic asthma: a cost-effectiveness analysis.评估美泊利珠单抗治疗重度嗜酸性粒细胞性哮喘的价值：一项成本效益分析。
Ann Allergy Asthma Immunol. 2017 Feb;118(2):220-225. doi: 10.1016/j.anai.2016.10.028. Epub 2016 Dec 4.
10
Patterns of Growth and Decline in Lung Function in Persistent Childhood Asthma.持续性儿童哮喘肺功能的生长与衰退模式
N Engl J Med. 2016 May 12;374(19):1842-1852. doi: 10.1056/NEJMoa1513737.
Zotero 插件